ABAdam Bess

Adam Bess

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Adam Bess has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Interpretable Drug–Target Prediction via Geometric Alignment: A Linear Alternative to Deep Architectural Complexity

    by Aashutosh Ghimire, Chris Alvin, Adam Bess, Supratik Mukhopadhyay

    Designing selective kinase inhibitors is a multiobjective optimization problem constrained by the structural conservation of the human kinome, along with the lack of high‐quality interaction data. Traditional deep learning methods often train complex neural networks directly on small datasets and fail to generalize to new chemical scaffolds. To this end, we present Geometric Manifold Alignment , a novel linear approach that shifts away from architectural complexity. We introduce Multi‐View Linear Manifold ( MVLM ), which aligns the latent spaces of ChemBERTa (small molecules) and ESM‐2 (protein sequences) into a shared geometric interaction space. We pretrain MVLM on the Universal Foundation Set of 473 923 high‐confidence interactions, where binding affinity is represented as geometric proximity between drug and target embeddings. Achieving an AUROC of 0.936 on KIBA and 0.928 on Davis, MVLM establishes the new state‐of‐the‐art on industry‐standard benchmarks, outperforming existing methods ( p < 0.001). In this work, interpretability is geometric where interaction scores are cosine similarities in a shared manifold, and the learned structure recovers kinase phylogenetic relationships without supervision. We also demonstrate the model’s utility as a transparent discovery engine by retrieving known clinical targets of FDA‐approved drugs. Our findings suggest that aligning pretrained chemical and biological representations provides a scalable and interpretable approach to advancing computational drug discovery.

  • Open Access

    e MolFrag 2 and e Synth 2: Sound Fragment-Based Molecular Decomposition and Reconstruction

    by Adam Bess, Sean Rowland, Chris Alvin, Meisam Adibifard, Supratik Mukhopadhyay

    We present eMolFrag2 and eSynth2, enhanced successors to eMolFrag and eSynth for fragment-based molecular decomposition and reconstruction. eMolFrag2 is a complete reimplementation of eMolFrag in Python, using RDKit and graph-based molecular representations to preserve connectivity, identify free atoms, combine adjacent linkers, and avoid aromaticity ambiguities that impair downstream reconstruction. eSynth2 generalizes fragment recombination by removing hard-coded molecular-property filters, supporting multiple bonds to a single brick atom, and adding a targeted reconstruction mode for soundness validation. Across 36,534 nonredundant DUD-E active compounds, the eMolFrag2 → eSynth2 workflow reconstructed every input molecule exactly (Tanimoto coefficient, TC = 1.0), whereas the original eMolFrag→ eSynth workflow reconstructed 51 of the 100 molecules in a benchmark subset. The upgraded workflow also produced broader recombinant chemical spaces, including higher entropy in a four-molecule diversity analysis (2.78 versus 2.70). Both tools are open-source, platform-agnostic, and available for academic and commercial use.

  • Open Access

    A multimodal human protein embeddings database: DeepDrug Protein Embeddings Bank (DPEB)

    by Saiful Islam Sajol, Magesh Rajasekaran, Hayden Gemeinhardt, Adam Bess, Chris Alvin, Supratik Mukhopadhyay

    Computationally predicting protein–protein interactions (PPIs) is challenging due to the lack of integrated, multimodal protein representations. DeepDrug Protein Embeddings Bank (DPEB) is a curated collection of 22 043 human proteins that integrates four embedding types: structural (AlphaFold2), transformer-based sequence (BioEmbeddings), contextual amino acid patterns (ESM-2: Evolutionary Scale Modeling), and sequence-based n-gram statistics (ProtVec). AlphaFold2 protein structures are available through public databases (e.g. AlphaFold2 Protein Structure Database), but the internal neural network embeddings are not. DPEB addresses this gap by providing AlphaFold2-derived embeddings for computational modeling. Our benchmark evaluations show GraphSAGE with BioEmbedding achieved the highest PPI prediction performance (87.37% AUROC, 79.16% accuracy). The framework also achieved 77.42% accuracy for enzyme classification and 86.04% accuracy for protein family classification. DPEB supports multiple graph neural network methods for PPI prediction, enabling applications in systems biology, drug target identification, pathway analysis, and disease mechanism studies.

  • Open Access

    KG-DTA: A knowledge graph-based meta-path learning framework to predict drug-target binding affinity

    by Amit Ranjan, Adam Bess, Saiful Islam Sajol, Magesh Rajasekaran, Chris Alvin, Supratik Mukhopadhyay